AME Case Reports is indexed in Emerging Sources Citation Index (ESCI): a significant step forward

Published: 2022-06-08

We are pleased to share a great news received on May. 30th, 2022 that AME Case Reports (Figure 1) has been selected for coverage in Clarivate Analytics products and services, Web of Science. Beginning with Vol 1 (1) 2020, this publication will be indexed and abstracted in Emerging Sources Citation Index, Web of Science.

Figure 1 Journal Cover.

Launched in September 2017, the journal AME Case Reports (ACR, AME Case Rep, Online ISSN: 2523-1995) is an international, open access, peer-reviewed online journal publishing original and educationally valuable case reports. ACR is indexed in PubMed and PMC in 2018. Cases that present diagnostic, ethical or management challenges, or that focus on mechanisms of injury, pharmacology or histopathology are deemed of particular educational valve. So that ACR will serve as a platform to provide clinically information on common and rare cases for healthcare professionals, researchers and readers.

As a dedicated platform, where key questions in the field of ACR may be answered, ACR publishes flexible and diverse article genres in a fast electronic publication mode. Till now, ACR has published 192 articles (Figure 2).

Figure 2 Number of published articles (data collected up to Jun 2022).

With an internationalized editorial board as a strong base, ACR further gains support from authors and reviewers from all over the world. It is with their joint efforts that high-quality publications are guaranteed. Corresponding authors are mainly from USA, China, Japan, Brazil, Italy and UK (Figure 3).

Figure 3 Geographical distribution of corresponding authors (data collected up to Jun 2022).

Being indexed by ESCI is undoubtedly a significant step for ACR. We look forward to the continued international teamwork to build ACR an invaluable publication serving our scientists, doctors, patients and students, and welcome more and more excellent international peers and colleagues to join this endeavor.